Salarius Pharmaceuticals, Inc (SLRX)

Etorro trading 970x250
Salarius Pharmaceuticals, Inc (SLRX) Logo

About Salarius Pharmaceuticals, Inc

Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. The company’s lead candidate is Seclidemstat (SP-2577), which is in Phase I/II clinical trial for the treatment of advanced solid tumors, including prostate, breast, and ovarian cancers, as well as Ewing sarcoma. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds; HLB Life Sciences to develop, produce, manufacture, use, and sell the drug in South Korea; and Cancer Prevention and Research Institute of Texas for product development activities. Salarius Pharmaceuticals, Inc. is headquartered in Houston, Texas. Address: 2450 Holcombe Boulevard, Houston, TX, United States, 77021

Salarius Pharmaceuticals, Inc News and around…

Latest news about Salarius Pharmaceuticals, Inc (SLRX) common stock and company :

71 Biggest Movers From Yesterday
20 May, 2022 FinancialContent

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA ...

38 Stocks Moving In Thursday's Mid-Day Session
19 May, 2022 FinancialContent

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
19 May, 2022 FinancialContent

Gainers Indaptus Therapeutics (NASDAQ:INDP) shares moved upwards by 28.8% to $3.22 during Thursday's pre-market ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
19 May, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time to tackle the biggest pre-market stock movers for this morning as we get ready for trading hours to start on Thursday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

24 Stocks Moving in Thursday's Pre-Market Session
19 May, 2022 FinancialContent

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) shares rose 20.9% to $0.70 in pre-market trading after dropping 12% on Wednesday. ...

76 Biggest Movers From Yesterday
19 May, 2022 FinancialContent

Gainers Bright Green Corp. (NASDAQ: BGXX) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on ...

Salarius Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference
18 May, 2022 Yahoo! Finance

HOUSTON, May 18, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other solid and hematological cancers, today announced that David Arthur, CEO of Salarius Pharmaceuticals, will be virtually presenting at the H.C. Wainwright Global Investment Conference being held on May 23-26, 2022. The presentation will provide an overview of recent business an

110 Biggest Movers From Friday
16 May, 2022 FinancialContent

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend ...

12 Health Care Stocks Moving In Friday's Intraday Session
13 May, 2022 FinancialContent

Gainers PolarityTE (NASDAQ:PTE) stock moved upwards by 48.2% to $0.22 during Friday's regular session. As of 13:30 ...

56 Stocks Moving In Friday's Mid-Day Session
13 May, 2022 FinancialContent

Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies ...

12 Health Care Stocks Moving In Friday's Pre-Market Session
13 May, 2022 FinancialContent

Gainers Calithera Biosciences (NASDAQ:CALA) shares increased by 37.2% to $0.22 during Friday's pre-market session. ...

23 Stocks Moving in Friday's Pre-Market Session
13 May, 2022 FinancialContent

Gainers OTR Acquisition Corp. (NASDAQ: OTRA) rose 88.7% to $18.21 in pre-market trading after filing on Thursday showed ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
13 May, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! We're starting off the final day of the workweek with an overview of the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

90 Biggest Movers From Yesterday
13 May, 2022 FinancialContent

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. ...

Salarius Pharmaceuticals: Q1 Earnings Insights
12 May, 2022 FinancialContent

Salarius Pharmaceuticals (NASDAQ:SLRX) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors ...

12 Health Care Stocks Moving In Thursday's After-Market Session
12 May, 2022 FinancialContent

Gainers Calithera Biosciences (NASDAQ:CALA) shares moved upwards by 29.7% to $0.21 during Thursday's after-market session. Today's ...

Salarius Pharmaceuticals Reports Business Highlights with First Quarter 2022 Financial Results
12 May, 2022 Yahoo! Finance

Salarius Successfully Completes SP-3164 Pre-IND Meeting Process with FDA Advancing multiple drug development programs, led by SP-3164 in targeted protein degradation, and seclidemstat in protein inhibition, a clinical-stage reversible LSD1 inhibitor Multiple potential development and data milestones expected from both programs in 2H 2022 2022 Annual Meeting of Stockholders announced for June 15, 2022; Company is encouraging all stockholders to participate and vote their shares of Salarius Pharma

58 Stocks Moving In Thursday's Mid-Day Session
12 May, 2022 FinancialContent

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena ...

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
12 May, 2022 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BridgeBio Inks Licensing ...

28 Stocks Moving in Thursday's Pre-Market Session
12 May, 2022 FinancialContent

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 89.7% to $0.1480 in pre-market trading after declining 9% on Wednesday. ...

Earnings Scheduled For May 12, 2022
12 May, 2022 FinancialContent

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its ...

12 Health Care Stocks Moving In Wednesday's After-Market Session
11 May, 2022 FinancialContent

Gainers Salarius Pharmaceuticals (NASDAQ:SLRX) stock increased by 24.7% to $0.2 during Wednesday's after-market session. Salarius ...

Salarius Pharmaceuticals Successfully Completes pre-IND Meeting with FDA for SP-3164
11 May, 2022 FinancialContent

Salarius Pharmaceuticals, Inc.(NASDAQ: SLRX) successfully completed the pre-IND (Investigational New Drug) meeting process with ...

Salarius Pharmaceuticals Completes SP-3164 Pre-Investigational New Drug Meeting Process with the U.S. Food and Drug Administration
11 May, 2022 Yahoo! Finance

Salarius planning for SP-3164 IND Application Submission in 2023HOUSTON, May 11, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, hematologic cancers and other cancers, today announced the successful completion of its pre-IND (Investigational New Drug) meeting process with the U.S. Food and Drug Administration (FDA) for SP-3164. SP-3164 is a next-gen

Salarius Pharmaceuticals's Earnings: A Preview
11 May, 2022 FinancialContent

Salarius Pharmaceuticals (NASDAQ:SLRX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what ...

Salarius Pharmaceuticals to Report First Quarter 2022 Financial Results and Highlight Recent Company Progress
05 May, 2022 Yahoo! Finance

Conference Call and Live Audio Webcast Scheduled for Thursday, May 12, 2022, 5:00 p.m. ETHOUSTON, May 05, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options, today announced that the Company will host a conference call and live audio webcast on Thursday, May 12, 2022, at 5:00 p.m. ET, to discuss its corporate and financial results for the three months ended Ma

61 Biggest Movers From Yesterday
28 Apr, 2022 FinancialContent

Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
27 Apr, 2022 FinancialContent

Gainers Cosmos Holdings (NASDAQ:COSM) shares rose 68.6% to $1.79 during Wednesday's regular session. Cosmos ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
27 Apr, 2022 FinancialContent

Gainers Cosmos Holdings (NASDAQ:COSM) stock increased by 117.0% to $2.3 during Wednesday's pre-market session. The ...

55 Biggest Movers From Friday
25 Apr, 2022 FinancialContent

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals ...

Salarius Pharmaceuticals, Inc (SLRX) is a NASDAQ Common Stock listed in , ,

970x250